Related references
Note: Only part of the references are listed.Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation
Mengyue Pei et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma
Kelly R. Rhodes et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Paula M. Cevaal et al.
ACS NANO (2021)
PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance
Peter Y. Li et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration
Stephanie M. Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy
Ping Xiao et al.
NANO LETTERS (2021)
A Supramolecular Trident for Cancer Immunotherapy
Xinxin Li et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Margaret M. Billingsley et al.
NANO LETTERS (2020)
In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
Stephany Y. Tzeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
Katharina Reinhard et al.
SCIENCE (2020)
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
Giulia Parisi et al.
NATURE COMMUNICATIONS (2020)
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
Kuan-Wei Huang et al.
SCIENCE ADVANCES (2020)
Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells
Junya Ichikawa et al.
CLINICAL CANCER RESEARCH (2020)
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan et al.
ACS NANO (2020)
Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction
Kelly R. Rhodes et al.
ACTA BIOMATERIALIA (2020)
Controlling timing and location in vaccines
Darrell J. Irvine et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Engineered Nanoparticles for Cancer Vaccination and Immunotherapy
Marisa E. Aikins et al.
ACCOUNTS OF CHEMICAL RESEARCH (2020)
The extent and drivers of gender imbalance in neuroscience reference lists
Jordan D. Dworkin et al.
NATURE NEUROSCIENCE (2020)
Targeted Activation of T Cells with IL-2-Coupled Nanoparticles
Verena K. Raker et al.
CELLS (2020)
Gene delivery for immunoengineering
Sarah Y. Neshat et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
N. N. Parayath et al.
NATURE COMMUNICATIONS (2020)
Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter
Siawosh K. Eskandari et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: influence of surface properties on dendritic cell activation
S. Barillet et al.
NANOTOXICOLOGY (2019)
Engineering an Artificial T-Cell Stimulating Matrix for Immunotherapy
John W. Hickey et al.
ADVANCED MATERIALS (2019)
PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses
Shilong Song et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma
Ni Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
Guorong Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
T cell immunotherapy enhanced by designer biomaterials
Zachary S. Dunn et al.
BIOMATERIALS (2019)
Systematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated Antigen
Rui-Jun Eveline Li et al.
FRONTIERS IN CHEMISTRY (2019)
Cancer Immunotherapy of TLR4 Agonist-Antigen Constructs Enhanced with Pathogen-Mimicking Magnetite Nanoparticles and Checkpoint Blockade of PD-L1
Giordano Traini et al.
SMALL (2019)
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy
John-Michael Williford et al.
SCIENCE ADVANCES (2019)
Discovery of Small Molecules for the Reversal of T Cell Exhaustion
Brett S. Marro et al.
CELL REPORTS (2019)
Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
Leyuan Ma et al.
SCIENCE (2019)
Polymeric micro- and nanoparticles for immune modulation
Elana Ben-Akiva et al.
BIOMATERIALS SCIENCE (2019)
Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles
Yu-Sang Sabrina Yang et al.
BIOMATERIALS SCIENCE (2019)
Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets
Sanne Duinkerken et al.
THERANOSTICS (2019)
B Cell-Based Cancer Immunotherapy
Kerstin Wennhold et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis
Stephen J. Gaudino et al.
FRONTIERS IN IMMUNOLOGY (2019)
Optimized DNA electroporation for primary human T cell engineering
Zhang Zhang et al.
BMC BIOTECHNOLOGY (2018)
Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors
Lihua Luo et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
Wenquan Ou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation
Alyssa K. Kosmides et al.
NANO LETTERS (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
Role of PD-1 during effector CD8 T cell differentiation
Eunseon Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Improving Vaccine and Immunotherapy Design Using Biomaterials
Michelle L. Bookstaver et al.
TRENDS IN IMMUNOLOGY (2018)
Antigen-Free Radionuclide-Embedded Gold Nanoparticles for Dendritic Cell Maturation, Tracking, and Strong Antitumor Immunity
Sang Bong Lee et al.
ADVANCED HEALTHCARE MATERIALS (2018)
CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
Natnaree Siriwon et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Cellular Uptake of Nanoparticles versus Small Molecules: A Matter of Size
Jesus Mosquera et al.
ACCOUNTS OF CHEMICAL RESEARCH (2018)
Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties
John W. Hickey et al.
BIOMATERIALS (2018)
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Hua Wang et al.
NATURE MATERIALS (2018)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
Jianbo Jia et al.
FRONTIERS IN ONCOLOGY (2018)
B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen
Sheng Hong et al.
IMMUNITY (2018)
Nanoparticle Vaccines Against Infectious Diseases
Rashmirekha Pati et al.
FRONTIERS IN IMMUNOLOGY (2018)
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Nataschja I. Ho et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity
Farideh Ordikhani et al.
JCI INSIGHT (2018)
Nanoparticle Manufacturing - Heterogeneity through Processes to Products
Samuel M. Stavis et al.
ACS APPLIED NANO MATERIALS (2018)
Gendered Citation Patterns across Political Science and Social Science Methodology Fields
Michelle L. Dion et al.
POLITICAL ANALYSIS (2018)
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Tyrel T. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy
Chuangnian Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination
Mona O. Mohsen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Tyrel T. Smith et al.
NATURE NANOTECHNOLOGY (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid et al.
NATURE COMMUNICATIONS (2017)
Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing
Timothy Z. Chang et al.
BIOMATERIALS SCIENCE (2017)
Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells
Nicholas M. Molino et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Trial watch: Dendritic cell-based anticancer immunotherapy
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2017)
Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells
Nicholas M. Molino et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Quantitative evaluation of gender bias in astronomical publications from citation counts
Neven Caplar et al.
NATURE ASTRONOMY (2017)
Surface engineering for lymphocyte programming
Elana Ben-Akiva et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy
Qanmei Zhang et al.
ACS NANO (2017)
Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth
Gijung Kwak et al.
ACS NANO (2017)
Gene Therapy 2017: Progress and Future Directions
A. M. Keeler et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth
Alyssa K. Kosmides et al.
ACS NANO (2017)
Dendritic cells in cancer: the role revisited
Filippo Veglia et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
Kevin A. Hay et al.
DRUGS (2017)
Biomimetic biodegradable artificial antigen presenting with PD-1 blockade to treat melanoma cells synergize
A. K. Kosmides et al.
BIOMATERIALS (2017)
B Cells Loaded with Synthetic Particulate Antigens: A Versatile Platform To Generate Antigen-Specific Helper T Cells for Cell Therapy
Antoine Sicard et al.
NANO LETTERS (2016)
Interleukin-2 Functionalized Nanocapsules for T Cell-Based lmmunotherapy
Stefanie U. Frick et al.
ACS NANO (2016)
Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody
Chao Wang et al.
ADVANCED MATERIALS (2016)
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
Marie de Charette et al.
EUROPEAN JOURNAL OF CANCER (2016)
Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy
Sander Kelderman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Stephanie L. Goff et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Nanotechnology for protein delivery: Overview and perspectives
Mikyung Yu et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade Enhanced Cancer Photodynamic Immunotherapy
Dangge Wang et al.
NANO LETTERS (2016)
Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy
Honglin Jin et al.
THERANOSTICS (2016)
An Overview of B-1 Cells as Antigen-Presenting Cells
Ana F. Popi et al.
FRONTIERS IN IMMUNOLOGY (2016)
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
Anke Redeker et al.
FRONTIERS IN IMMUNOLOGY (2016)
Toxicity and management in CAR T-cell therapy
Challice L. Bonifant et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Multivalent Antigens for Promoting B and T Cell Activation
Nitasha R. Bennett et al.
ACS CHEMICAL BIOLOGY (2015)
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy
Karlo Perica et al.
ACS NANO (2015)
Elasticity of Nanopartides Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting
Aaron C. Anselmo et al.
ACS NANO (2015)
Paracrine co-delivery of TGF-beta and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells
Michael D. McHugh et al.
BIOMATERIALS (2015)
Human Primary Immune Cells Exhibit Distinct Mechanical Properties that Are Modified by Inflammation
Nathalie Bufi et al.
BIOPHYSICAL JOURNAL (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells
Heiko Bruns et al.
CLINICAL CANCER RESEARCH (2015)
Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation
Randall A. Meyer et al.
SMALL (2015)
Harnessing nanopartricles for immune modulation
Daniel R. Getts et al.
TRENDS IN IMMUNOLOGY (2015)
Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines
Cleo Goyvaerts et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
Antibody-independent functions of B cells: a focus on cytokines
Ping Shen et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
Karlo Perica et al.
ACS NANO (2014)
Particle shape dependence of CD8+T cell activation by artificial antigen presenting cells
Joel C. Sunshine et al.
BIOMATERIALS (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
Isabel Poschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Oxidized Multiwalled Carbon Nanotubes as Antigen Delivery System to Promote Superior CD8+ T Cell Response and Protection against Cancer
Paula Cristina Batista de Faria et al.
NANO LETTERS (2014)
Nanoparticle Chemistry and Functionalization Differentially Regulates Dendritic Cell-Nanoparticle Interactions and Triggers Dendritic Cell Maturation
Jonathan T. Goodman et al.
PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION (2014)
Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo
Kenichi Niikura et al.
ACS NANO (2013)
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2013)
Nanoscale Ligand Spacing Influences Receptor Triggering in T Cells and NK Cells
Derfogail Delcassian et al.
NANO LETTERS (2013)
Nanoengineering approaches to the design of artificial antigen-presenting cells
Joel C. Sunshine et al.
NANOMEDICINE (2013)
Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms
Rachit Agarwal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Graphene Oxide, But Not Fullerenes, Targets Immunoproteasomes and Suppresses Antigen Presentation by Dendritic Cells
Alexey V. Tkach et al.
SMALL (2013)
Gendered Citation Patterns in International Relations Journals
Sara McLaughlin Mitchell et al.
INTERNATIONAL STUDIES PERSPECTIVES (2013)
Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using pathogen-like amphiphilic polyanhydride nanoparticles
Ana V. Chavez-Santoscoy et al.
BIOMATERIALS (2012)
Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
Richard Wu et al.
CANCER JOURNAL (2012)
B-Cell Cross-Presentation of Autologous Antigen Precipitates Diabetes
Eliana Marino et al.
DIABETES (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park et al.
NATURE MATERIALS (2012)
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis
Ada Yeste et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Whole Cell Vaccines-Past Progress and Future Strategies
Bridget P. Keenan et al.
SEMINARS IN ONCOLOGY (2012)
The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway
Tomofumi Uto et al.
BIOMATERIALS (2011)
The impact of nanoparticle ligand density on dendritic-cell targeted vaccines
Arunima Bandyopadhyay et al.
BIOMATERIALS (2011)
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells
Fabian Blank et al.
NANOTOXICOLOGY (2011)
Amphiphilic Poly(Amino Acid) Nanoparticles Induce Size-Dependent Dendritic Cell Maturation
Hyungjin Kim et al.
ADVANCED FUNCTIONAL MATERIALS (2010)
Polymer particle shape independently influences binding and internalization by macrophages
Gaurav Sharma et al.
JOURNAL OF CONTROLLED RELEASE (2010)
T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing
Coen Govers et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Signalling through C-type lectin receptors: shaping immune responses
Teunis B. H. Geijtenbeek et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Julie A. Champion et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Adoptive T cell therapy for cancer in the clinic
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Share Paper
